机译:拍摄是难治性无限卡斯克曼疾病的潜在治疗选择吗?
Department of HaematologyUniversity Hospitals of Bristol NHS TrustBristol UK;
Department of HaematologyUniversity Hospitals of Bristol NHS TrustBristol UK;
Division of Otolaryngology and Head and Neck SurgeryJohn Hopkins School of MedicineBaltimore MD USA;
Department of HaematologyUniversity Hospitals of Bristol NHS TrustBristol UK;
Department of Cellular PathologyUniversity Hospitals Bristol NHS TrustBristol UK;
Department of DermatologyUniversity Hospitals of Bristol NHS TrustBristol UK;
Department of Oral MedicineUniversity Hospitals of Bristol NHS TrustBristol UK;
Department of RadiologyUniversity Hospitals of Bristol NHS TrustBristol UK;
Department of HaematologyUniversity Hospitals of Bristol NHS TrustBristol UK;
cytokine storm; IL‐6; tocilizumab; unicentric Castleman disease ( UCD );
机译:拍摄是难治性无限卡斯克曼疾病的潜在治疗选择吗?
机译:Tocilizumab作为患有严重难治性少年局部化硬皮病的儿童的潜在治疗选择
机译:原因不明的难治性铁缺乏症贫血的罕见原因:单中心浆细胞型Castleman病
机译:HL161,一种新型抗FCRN抗体,作为致病IgG介导的自身免疫疾病的新治疗选择
机译:通过改进的LC-MS为基础的化学计量方法,通过改进的LC-MS的化学计量方法从疫苗和肺部疾病的天然产物治疗潜力
机译:单中心Castleman病影响的脊柱关节炎患者通过手术切除和Tocilizumab治疗得到有效治疗
机译:Tocilizumab是难治性单中心性Castleman病的潜在治疗选择吗?